Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5192_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
67 Мб
Скачать
8.13 Surgical Complications and Measures to Avoid Them
Dermatologic Surgery
Procedure
High risk of
No Prophylaxis
No
surgical site
infection
High risk for prosthetic
joint infectionb or
infective endocarditisc?
No
Consider
prophylaxis
Lesions below the knee (including groin)
Cephalexin 2g PO
If PCN allergic,
Bactrim DS 1 tablet PO or Levofloxacin 500 mg PO
Skin graft (any site) Wedge excision (ear, lip) Flap surgery on the nose and ear
Cephalexin 2g PO
If PCN allergic,
Clindamycin 600 mg PO or
Azithromycin 500 mg PO or
Clarithromycin 500 mg PO
Fig. 8.22 Updated prophylaxis algorithm for dermatologic surgery. (From Bae-Harboe YS, Liang CA. Perioperative antibiotic use of dermatologic surgeons in 2012.
Dermatol Surg. 2013;39[11]:1592–1601.)
Breach of oral mucosa?
No
a
?
Yes
Yes
Prophylaxis
recommended
Yes
High risk for
prosthetic joint
infectionb?
No
High risk for
infective
endocarditisc?
No
No prophylaxis
Yes
Yes
Consider
prophylaxis
Prophylaxis
Amoxicillin 2 g PO If PCN allergic, Clindamycin 600 mg PO or Azithromycin 500 mg PO or Clarithromycin 500 mg PO
recommended
First 2 years following joint placement Previous prosthetic joint infections Immunocompromised/immunosuppressed patients Diabetes (Type 1 and 2) Autoimmune disease Post organ transplants Receiving Chemotherapy Bone marrow transplant recipients Chronic steroid users Obesity Tobacco exposure Alcohol use History of radiation therapy Eiderly HIV infection Malignancy (including leukemia) Malnourishment Hemophilia
C) High risk of infective endocarditis
Prosthetic cardiac valve Previous infective endocarditis Unrepaired cyanotic congenital heart disease including palliative shunts and conduits Completely repaired congenital heart defects with prosthetic material or device < 6 months after procedure Repaired congenital heart disease with residual defects at or adjacent to site of prosthetic patch or device Cardiac transplantation recipients who develop cardiac valvulopathy
Venous congestion: cyanotic-purple skin color,
dark purple bleeding following pinprick test; aps undergo rapid necrosis (,3–4 hours)
■
Risk factors:
Hematoma, infection, wound tension, tight sutures (“edge necrosis”), extensive supercial undermining ( damage subdermal plexus), insufcient or excessive electrocoagulation, poor ap planning (narrow pedicle), smoking/nicotine
■
Prevention: appropriate intraoperative hemostasis, minimize wound closure tension
■
Treatment: suture replacement ( tension), elevation ( edema), heat application ( circulation), and hyperbaric oxygen ( oxygenation)
Do NOT debride necrotic tissue (unless shows signs of infection) since it serves as a biologic dressing
Dehiscence
■
Separation of wound edges as a result of excessive tension, hematoma, infection, or necrosis
■
Highest risk 5 time of suture removal (1–2 weeks)
Consider removing sutures in stages if prolonged support is needed
■
Treatment:
Classic teaching: re-suture if within 24 hours; if $ 24 hours let it granulate on its own
Recent literature supports re-suturing if no infection, hematoma, necrosis, or after underlying complication has been treated
Abnormal healing
■
Chondritis: painful (test by “icking” ear); may occur after any ear procedure involving cartilage; may be a/w Pseudomonas infection; treat w/ NSAIDs 1 quinolones (if infected)
■
Contour irregularities: treated w/ dermabrasion/ dermasanding (6 weeks postoperatively), ablative
laser, or excision
■
Ectropion:
Cause: downward tension on lower lid Risk factors: poor recoil on “snap test” Prevention: tacking sutures to periosteum and Frost suspension sutures
■
Eyebrow elevation: avoid closures that elevate brow . 3 mm (classic teaching)
Recent studies have actually shown that any brow asymmetry from horizontal forehead closures self­resolves over time
■
Free margin distortion: avoided w/ proper surgical design
■
Keloids: often patient- and site-specic (anterior neck, chest, shoulders, and scars crossing jawline); treat w/ intralesional corticosteroids
475
CHAPTER 8 Dermatologic Surgery
■
Pincushioning/trapdoor deformity:
Risk factors: frequently due to concentric contractile forces → aps w/ curved incision lines have highest risk (e.g., bilobed aps, nasolabial transposition/interpolation aps) Prevention: wide undermining, appropriate sizing of ap, remove excess SQ fat on ap, ensure ap adherence to wound base Treatment: intralesional corticosteroids (into SQ) 1/– scar revision
■
Spitting sutures: risk w/ Vicryl, larger caliber sutures, or sutures placed supercially in dermis; occurs 1 to 3 months postop; remove if possible (use Jeweler’s forceps if suture not visible on surface)
■
Suture granuloma: risk w/ Vicryl, occurs 1 to 3 months postop; self-resolves without sequelae, but may treat w/ intralesional steroids
■
on nose and central cheeks; treated w/ pulsed dye laser
■
Thickened scars: treated w/ massage or intralesional corticosteroids
■
“Track marks”: do not tie sutures too tightly or leave in place for too long; consider running subcuticular epidermal closure
More common on trunk/extremity closures since sutures typically left in longer and under greater tension compared to face
■
Webbed or contracted scars: consider Z-plasty revision
Motor nerve damage
■
Most severe if nerve transected at its proximal portion frequently permanent
■
Avoided by staying above SMAS
Sensory nerve damage
■
Generally improves with time
■
Minimize by avoiding transection of multiple sensory nerve branches (e.g., orienting linear repairs on forehead vertically rather than horizontally)

8.14 SCAR IMPROVEMENT

Overview
Scars mature over at least 2 years, but if not exhibiting
favorable characteristics, may consider intervention after 60 to 90 days
Manage expectations
■
Goal is to improve, not erase
Result depends on
■
Size
■
Location
■
Patient’s predisposition for appropriate wound healing
Favorable scars
■
Positioned along aesthetic subunit borders
■
Parallel with RSTLs
Nonsurgical modalities
Watchful waiting
Massage
■
Efcacy greatest in postsurgical scars
■
Often best for subtle imperfections
Mild webbing, scar depression, or pincushioning
Pressure therapy
■
Efcacy greatest during scar maturation (rst year) and limited thereafter
■
Mechanism of action
Pressure → ↓ blood ow and oxygen → ↑ collagen breakdown
Topical scar therapies
■
Silicone sheeting and gel
Mechanism unclear Side effects: skin maceration and rash
■
Vitamin E
Efcacy not proven in clinical trials Noted to cause allergic contact dermatitis
■
Steroids
Mechanism of action
♦ Binding of nuclear steroid receptor ♦ Decrease activity of broblasts and decreases
collagen production
Clinical activity
♦ Softens scars, hypertrophy, pincushioning
Group I steroids most efcacious, but risk of side effects
■
Imiquimod
Mechanism of action
♦ Stimulates IFN-a → ↑ collagen breakdown,
TGF-b (note: TGF-b levels are a/w keloid
formation)
Clinical activity
♦ Prevention of keloid recurrence after excision ♦ Results of studies have been mixed
Cream is applied nightly for 8 weeks
Intralesional therapies
■
Steroids
Primarily used for hypertrophic and keloidal scars Mechanism of action and clinical activity: same as for topical steroids Consider intraoperative injection if patient has a history of keloids
■
5-FU
Primarily used for hypertrophic and keloidal scars Can be used in combination w/ steroids Mechanism of action
♦ Blocks TGF-b2 gene in broblasts → ↓ collagen
production → softens scars and ↓ hypertrophy
Lasers
■
Pulsed dye laser (585–595 nm)
Laser of choice for red, hyperemic, pigmented, or hypertrophic scars and keloids Patient phototype important as melanin competes for laser absorption. Must use lower energy densities in darker skin tones Mechanism of action
♦ Keloids: nonspecic heating of dermal collagen
promotes scar remodeling
♦ Redness: destruction of dermal vessels
■
Nd:YAG (1064 nm)
Noted to improve pigmentation, vascularity, pliability and height of keloids and hypertrophic scars
476
■
Resurfacing lasers
Mechanism of action
♦ Dermal heating leads to scar remodeling
Types
♦ Ablative (CO
Destroys stratum corneum ( recontouring
10,600 nm; Erb:YAG 2940 nm)
2
surface irregularities) and deeper structures (dermal heating scar remodeling)
Uses: recontouring atrophic scars reported
equivalent cosmesis to dermabrasion w/ faster clinical recovery
♦ Nonablative
Preserves stratum corneum with destruction of
deeper structures
Radiotherapy
■
Reserved for scars that are unresponsive to other treatments
■
Not adequate as monotherapy for keloids
■
Frequently combined with surgical resection
■
Mechanism of action
Collagen synthesis due to broblast proliferation and apoptosis
■
Best results reported w/ 15 to 20 Gy over 5 to 6 sessions in early postoperative period; typically started 24 to 48 hours after surgery
Surgical modalities
Dermabrasion/electrobrasion
■
Dermabrasion
Mechanism of action: epidermis and papillary dermis are removed allows wound to reepithelialize from surrounding epithelium and underlying adnexa Best performed 6 to 8 weeks postoperatively Re-wounding during brillogenesis → ↑ epidermal cell migration into wound → improved appearance of scar Variants:
♦ Wire brush
Creates microscopic lacerations Less forgiving than diamond fraise
♦ Diamond fraise with hand engine
Should rotate in the direction of free
margin
Feathering used to avoid demarcation between
treated and untreated regions
♦ Dermasanding
Manually performed with medium-grade
drywall sanding screen, sandpaper, or surgical scratch pad (presterilized, equivalent to 80 grit sandpaper)
No aerosolization of infectious particles or
blood splatter
Side effects
♦ Hyper/hypopigmentation ♦ Milia formation ♦ Persistent erythema ♦ Paradoxical worsening of scars
■
Electrobrasion
Mechanism of action: controlled skin ablation w/ hyfrecator (low power)

8.15 Nail Surgery

Similar results to dermabrasion Procedure and bleeding time (vs. dermabrasion)
Subcision
■
Utilized on depressed facial scars
■
20-gauge tri-beveled hypodermic needle inserted in the skin and sharp edges are maneuvered to release brotic scar bands within dermis and subcutaneous tissue
Scar excision procedures
■
Linear excision of scar
■
W-plasty
Irregularization technique; typically followed by dermabrasion
■
Geometric broken line
Irregularization technique; incise connected random geometric gures (squares, rectangles, and triangles); typically followed by dermabrasion
Scar reorienting/lengthening techniques
■
V to Y
Can push (V–Y) or pull (Y–V) a free margin into place Less dramatic lengthening than Z-plasty
■
Z-plasty
Used to lengthen scar or release contractions Angle of the lateral arms relative to the central limb determines the amount of lengthening Greater angles more lengthening (though aps become harder to transpose over one another)
♦ 30° lengthens by 25% ♦ 45° lengthens by 50% ♦ 60° lengthens by 75% (Fig. 8.23)
8.15 NAIL SURGERY
Nail avulsion: typically undertaken for treatment of
onychomycosis, onychomadesis, nail biopsy, nail matrix ablation, or nail unit excision
■
Distal nail avulsion (most commonly used technique): entire nail is separated from distal nail bed to PNF
■
Proximal nail avulsion: less traumatic than distal nail avulsion; undertaken when there is thick subungual hyperkeratosis, prominent distal subungual damage or no distal free edge
■
Partial nail avulsion: used for onychocryptosis or when the exact location of the subungual lesion is already known
Nail biopsies (Fig. 8.24):
■
Nail bed:
Longitudinal excision; excision extends down to periosteum; 1/– suturing of defect (not required if defect width # 3 mm); minimal risk of nail
dystrophy
■
Nail matrix:
Horizontal excision; make diagonal 5 mm incision from PNF (extending proximally on nger) to allow visualization of matrix biopsy carried down to periosteum Matrix biopsies have risk of nail dystrophy/ thinning; highest risk w/ proximal matrix biopsies and if . 3 mm width
477
CHAPTER 8 Dermatologic Surgery
B
b
B
60°
A
D
60°
C
c
A B C
Fig. 8.23 Single Z-plasty, 60 degrees. (A) Central scar is the common diagonal. (B) Two triangular aps are lifted and transposed. (C) Result is approximately 75% increased tissue length. (From James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM. Dermatologic surgery. In: Andrews’ Diseases of the Skin. 13th ed. Philadelphia: Elsevier; 2020:881–908.)
b
B
C
c
D
A
c
b
C
75% tissue gain
D
Nail biopsies
6 mm
2
1
1
3–4mm
3
Fig. 8.24 Nail biopsies. Nail bed biopsy (1), lateral longitudinal biopsy (2), and fusiform matrix biopsy (3). (From Haneke E. Nail surgery. In: Robinson JK, Hanke CW, Siegel DM, Fratila A, eds. Surgery of the Skin . 3rd ed. Philadelphia, Elsevier, 2015:755–780.)
478

8.16 Wound Dressings

Most nail melanomas arise from matrix matrix biopsy required → ↑ risk of nail dystrophy
■
Lateral longitudinal nail biopsy:
Longitudinal excision of entire length of lateral nail unit (nail matrix, folds, bed, plate and hyponychium) Useful for lateral nail pathology or inammatory conditions in which nail matrix, folds, bed, and plate are concurrently involved Main risks 5 spicule or cyst formation
Nail unit excision:
■
En bloc excision is typically used for removal of malignancy such as subungual melanoma; aggressive procedure that may result in permanent stiffness of joint, but may be preferable to amputation
■
Excision must be taken back to DIP tendon insertion to remove entire matrix
Matricectomy
■
Removes nail matrix inability to form new nail
■
Indications: ingrown nail/onychocryptosis (#1) and intractable onychogryphosis
■
Typically only the part of the matrix causing problems needs to be removed
Table 8.23 Types and Characteristics of Occlusive/Moisture-Retentive Wound Dressings
Type Advantages Disadvantages Indications Examples
Foams Absorbent, conform to body
Films Transparent, create bacterial barrier,
Hydrocolloids
Hydrogels Semitransparent, soothing, do not
Alginates Highly absorbent, hemostatic,
From Levin Y, Brown KL, Phillips TJ. Wound healing and its impact on dressings and postoperative care. In: Robinson JK, Hanke CW, Siegel DM, Fratila A, eds.
Surgery of the Skin. 3rd ed. Philadelphia: Elsevier; 2015:114–133.
contours
adhesive without secondary dressing
(1) Autolytic debridement,
enhance angiogenesis, absorbent, create bacterial and physical barrier
adhere to wounds, hydrating
do not adhere to wounds, fewer dressing changes
Opaque, require
secondary dressing
May adhere to wounds,
can cause fluid collection
Opaque, gel has
unpleasant smell, expensive
Require secondary
dressing, frequent dressing changes
Require secondary
dressing, gel has unpleasant smell
■
Phenol matricectomy
After avulsion, phenol (88%) applied to matrix w/ cotton tipped applicator (2–3 passes) for 3 minutes total
♦ Attention to lateral matrix horns to avoid spicule
formation Nail folds and nail bed should be protected from phenol (w/ petrolatum) and phenol is neutralized
after nal pass w/ isopropyl alcohol
ECG monitoring is not necessary
■
Excision and electrodesiccation of the nail matrix have been advocated by some authors as alternatives to phenol; limited data exist on its benets and harms relative to other forms of nail matricectomy
■
Subungual hematoma:
Trephination indicated if hematoma . 50% of nail May occur in combination w/ fractured distal phalanx X-rays recommended
8.16 WOUND DRESSINGS
See Table 8.23
Partial-thickness wounds, moderately to
heavily exudative wounds, pressure relief
Donor sites, superficial burns and ulcers,
partial-thickness wounds with minimal exudates
Partial- or full-thickness wounds, mildly to
moderately exudative wounds, pressure ulcers, venous ulcers, donor sites, acute surgical wounds
Painful wounds, partial-thickness wounds,
wounds after laser, dermabrasion or chemical peel, donor sites
Highly exudative wounds, partial- or full-
thickness wounds, after surgery
Allevyn Flexzan Hydrasorb Lyofoam Vigifoam
Tegaderm Bioclusive BlisterFilm Omniderm Transeal
Duoderm Nu-Derm Comfeel Cutinova Replicare
Vigilon Tegagel Curagel ClearSite Cural Elasto-Gel SoloSite wound gel 2nd Skin
AlgiDerm AlgiSite Algisorb Kaltostat Curasorb Polymem SeaSorb Sorbsan
479
This page intentionally left blank
9

Cosmetic Dermatology

Ronda S. Farah
CONTENTS LIST
9.1 LASERS
9.2 BOTULINUM TOXIN
9.3 DERMAL FILLERS
9.4 LIPOSUCTION AND FAT REDUCTION
9.5 SCLEROTHERAPY AND VEIN MANAGEMENT
9.6 COSMECEUTICALS, NUTRACEUTICALS, AND OTHER SUPPLEMENTS
9.7 HAIR TRANSPLANTATION
9.8 CHEMICAL PEELS
9.9 OTHER ESTHETIC PROCEDURES AND SCALES
Acknowledgments: With acknowledgments to Addison Demer MD, Lori Fiessinger MD, Seaver Soon MD, Kaichu Lee MD, Neil Sadick MD, and the original author, Raja K. Sivamani.

9.1 LASERS

LASER 5 Light Amplication by Stimulated Emission of
Radiation (Table 9.1)
Lasers are characterized by the “3 Cs”
■
Coherence: light waves travel together in-phase in time and space
■
Collimation: light waves travel together in a parallel fashion
■
(mono) Chromatic: light waves are all the same wavelength
Three different media exist (determine laser wavelength):
■
Gas: CO2, xenon chloride (excimer laser), krypton, argon, copper vapor, helium-neon
■
Liquid: rhodamine dye (pulsed dye laser [PDL])
■
Solid: two classes exist
Crystal: alexandrite, Er-YAG, Nd-YAG, potassium titanyl phosphate (KTP), and ruby Semiconductor: diode
Selective photothermolysis: using a laser to achieve
selective destruction of the target structure(s); depends on three factors (Table 9.2):
■
Wavelength must target the desired chromophore and reach an appropriate anatomic depth to destroy the desired target tissue. Medium determines wavelength of laser.
■
Pulse duration should be # thermal relaxation time (TRT) minimizes diffusion of heat and resultant
“collateral damage” to surrounding tissues
■
Fluence must be high enough to damage target tissue, but not so high as to nonspecically damage bystander tissue
Four different types of laser wave forms:
■
Continuous: emit light continuously; low power (e.g., CO2 laser, and argon)
■
Pulsed: light is emitted periodically, with short pulse durations (millisecond [ms] range), and high power
(e.g., PDL, ruby, alexandrite, diode, Erbium:glass, and Erbium:YAG)
■
Quality switched (Q-switched [QS]): variant of pulsed lasers with extremely short pulse durations (nanosecond range); extremely high power (example: all QS lasers)
For pigmented lesions, tattoos, and drug deposits because target molecules are very small very short TRT (nanoseconds)
■
Quasicontinuous: emits multiple rapid bursts of low­energy light simulates continuous wave lasers (e.g., KTP and copper vapor)
Treated skin will have at least one of the following four
interactions with emitted laser light particles:
■
Reection: 4%–7% of light is reected (“bounced away”) by skin surface, as a result of the difference in refractive index between air and stratum corneum; the remaining 93%–96% of light enters skin and will subsequently interact in one of three following ways:
Scattering: light bounces off bers within dermis/SQ
limits depth of penetration Spot size → ↓ scatter → ↑ depth of penetration
Transmission: light passes straight through the tissue without interacting with anything → lack of any effect Absorption (desired effect): light is absorbed by its intended target tissue effects
481
CHAPTER 9 Cosmetic Dermatology
Table 9.1 Laser Terminology
Term Definition Unit Comments
Energy Fundamental unit of work Joules (J)
Fluence Energy delivered per cm
Power Rate of energy delivery
Irradiance Power delivered per cm
Pulse width (pulse
duration)
Spot size Diameter of the laser beam hitting the
Wavelength Length of a specic laser’s light wave
Chromophore Absorptive target tissue of laser Major chromophores in skin (boards favorite): melanin, hemoglo-
Thermal relaxation
time (TRT)
Photomechanical
effect
Duration of laser exposure (seconds) Seconds (or fractions
skin surface (mm)
Four categories:
UV (10–400 nm) Visible (400–700 nm) Infrared (700 nm–1 mm) Radiofrequency/microwaves (.1 mm)
The time required for heated tissue to
dissipate 50% of its heat
Sudden heating produces thermal
expansion with acoustic and/or shock waves waves produce cavitation (steam bubbles)
2
2
2
J/cm
Watts (W) 5 J/s
2
W/cm
of seconds)
mm
nm (most commonly) Longer wavelengths penetrate deeper (rule holds true until
Seconds (or fractions
of seconds); proportional to the diameter of target squared
fluence → ↑ energy of treatment per unit area
Pulse duration 5 longer exposure to the laser → ↑ energy/heat
delivered to tissue
Ideally, pulse duration should be # TRT to prevent collateral dam-
age to bystander tissues
Larger spot size → ↓ scatter → ↑ depth of penetration
1300 nm, at which point penetration decreases as a result of water absorption; Figure 9.1)
Most deeply penetrating wavelengths 5 650–1200 nm Least penetrating wavelengths 5 far UV and far IR
bin (oxyhemoglobin and deoxyhemoglobin), and water
A laser/light source may target multiple chromophores to differing
degrees
TRT (seconds) is proportional to the square of the target’s
diameter (in mm)
Ideally, pulse duration should be # TRT If pulse duration . TRT → ↑ undesired damage to surrounding tis-
sues (Table 9.2)
Cavitation is the primary mechanism of vessel rupture w/ PDL ,
and also is responsible for skin whitening during QS laser treatment of tattoos
Table 9.2 Thermal Relaxation Times of Chromophore
Chromophore Diameter Thermal Relaxation Times Typical Pulse Duration
Tattoo ink particle 0.1 micrometer 10 nanoseconds a. 0.6–10 nanoseconds (if Q-switched lasers)
Melanosome 0.5 micrometers 250 nanoseconds 10–100 nanoseconds (requires Q-switched lasers)
PWS vessels 30–100 micrometers 1–10 milliseconds 0.4–20 milliseconds
Terminal hair follicle 300 micrometers 100 milliseconds 3–100 milliseconds
Leg vein 1 millimeter 1 second
Modied from Sakamoto FH, Avram MM, Anderson RR. Lasers and other energy-based technologies—principles and skin interactions. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia: Elsevier; 2018:2354–2363.
■
Epidermal damage is minimized via skin cooling (three commonly used methods):
■
Precooling: most aggressive, most effective method (e.g., cryogen [tetrauoroethane] spray)
Main side effect (SE) 5 hyper/hypo-pigmentation
■
Parallel cooling: only effective for pulses . 5 ms in duration (e.g., solid cold sapphire window pressed
and reduction of periorbital rhytides; anti-aging/ photorejuventation applications exist (red light 633 nm and near-infrared light 800–830 nm)
A variety of lasers exist, each with specic wavelengths, target
chromophores, and depths of penetration (Figs. 9.1 and 9.2)
Non-laser light-based energy sources:
■
Intense pulsed light (IPL):
against skin)
■
Postcooling: used primarily to ↓ pain, erythema, and edema (e.g., ice packs and cold air)
Photobiomodulation (aka low level light therapy):
■
Mechanism unknown but chromophore thought to be mitochondrial cytochrome c oxidase; sources of light include lasers, light emitting diodes, broadband light (within the visible and near infrared spectrum)
■
Used for androgenetic alopecia (typically 655–678 nm and available as home or in-ofce devices), acne
vulgaris (blue light 415 nm and red light 633 nm)
0.1 seconds
Xenon ashlamp (light source) emits noncollimated, noncoherent, and polychromatic
light (broad wavelength range: 500–1200 nm) A variety of lters are utilized to narrow down the range of wavelengths to target the same chromophores that lasers do Less selective and less powerful than lasers; can be risky in patients with skin types IV–VI Targets lentigines, vascular lesions such as telangiectasias; caution when treating men on the face as it also removes hair
482
DEPTH OF OPTICAL PENETRATION BY VARIOUS LASERS
483
Excimer
Stratum
corneum
Epidermis
1 mm
Superficial
dermal blood
vessels
2 mm
3 mm
4 mm
Fig. 9.1 Depth of optical penetration by various lasers. It should be noted that the treatment depth can greatly exceed the optical penetration depth for ablative lasers. On the face, fat can be present at a depth of 2 to 3 mm. For example, the depth of optical penetration for CO2 lasers is only 20 microns, but fractional CO2 lasers can vaporize nearly full-thickness microchannels through the dermis. KTP, Potassium titanyl phosphate; Nd, neodymium; PDL, pulsed dye laser; YAG, yttrium aluminum garnet. (From Sakamoto FH, Avram MM, Anderson RR. Lasers and other energy-based technologies—principles and skin interactions. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia: Elsevier; 2018:2354–2363.)
Dermis
Deeper dermal
blood vessels
Subcutaneous
308 nm
80 2 20
fat
Argon
488–514 nm
KTP
532 nm
PDL
585–600 nm
Ruby
694 nm
Alexandrite
755 nm
Diode
800 nm
Nd:YAG
1064 nm
Erbium: Glass
1540 nm
Thulium
1927 nm
Erbium:YAG
2940 nm
CO
2
10,600 nm
9.1 Lasers
CHAPTER 9 Cosmetic Dermatology
100,000
)
-1
1000
Excimer
ABSORPTION SPECTRA
Ruby
Alexandrite
KTP, Nd:YAG
PDL
Diode
Nd:YAG
Er:Glass
Erbium
Thulium
YSGG
Er:YAG
Fig. 9.2 Absorption spectra. The heterogeneous absorption spectra of chromophores allow selective photothermolysis to work. Er, Erbium; KTP, potassium titanyl phosphate; Nd:YAG, neodymium-doped yttrium aluminum garnet; PDL, pulsed dye laser; YSGG, yttrium scandium gallium garnet. (From Sakamoto FH, Avram MM, Anderson RR. Lasers and other energy-based technologies—principles and skin interactions. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia: Elsevier; 2018:2354–2363.)
Laser safety
Four main concerns: blindness, re hazards, cutaneous
burns, and inhalation of biohazardous plume
Blindness
■
Up to 7% of emitted laser light is reected by the stratum corneum reected light can cause eye damage/blindness (may occur if even 1% of the beam is reected into eye!)
■
Blindness is rapid and painless
■
Any laser/light source in UV range (10–400nm) → lens damage, cataracts
Example: excimer laser (308 nm)
■
Any laser/light source that targets melanin or hemoglobin (visible light [400–700nm] and near- infrared [700–1400nm] wavelengths) → retinal damage (retina is highly pigmented); also damages uvea and iris
Examples: KTP (532 nm), PDL (585–600 nm), ruby (694 nm), IPL (various wavelengths), alexandrite (755 nm), diode (800 nm), and Nd:YAG (532 and 1064 nm) Highest risk 5 near-infrared and QS lasers
■
Any laser/light source that targets water (near-IR [upper end], mid-IR, far-IR wavelengths) corneal/scleral
damage
Examples: Nd:YAG (1320 nm), Erbium:glass (1550 nm), Erbium:YAG (2940 nm), and CO2 (10,600 nm)
Fire hazard
■
Greatest re risk with CO2 and Erbium:YAG ablative and fractionated lasers
■
Risks: drapes, clothing, dry hair, and plastic tubes (endotracheal tubes, especially if oxygen is being administered)
■
Prevention: moisten hair near treatment eld, ensure that any alcohol/acetone skin cleanser has fully dried before using laser, and reduce intraoperative O concentration , 40%
2
10
Absorption coefficient (cm
0.1 200 400 600 800 1000
Wavelength (nm)
Melanin Oxyhemoglobin Deoxyhemoglobin Water Fat
Cutaneous burns: may occur with any laser or nonlaser
energy source (IPL and radiofrequency [RF]); as a result of operator error or device malfunction (e.g., epidermal cooling mechanism fails)
Inhalation of biohazardous plume
■
HPV viral particles have been detected in carbon dioxide laser plumes cases of laser-surgeons developing HPV­16–induced oral SCC related to inhalation
■
Hepatitis B and HIV also reported in plume
■
Prevention: smoke evacuator (rst line); also recommend N95 mask
Other safety facts:
■
QS lasers can eject tissue due to cavitation
■
Beware of diseases that koebnerize with lasers (e.g., psoriasis and lichen planus)
■
Lasers can damage tooth veneers/dentures
■
Optical density (O.D.): found on laser glasses; is a logarithmic measure of the laser energy that will pass through a lter; higher O.D. value = higher energy attenuation → greater eye protection
Each unit represents a 10-fold reduction in transmitted laser light (O.D. 1 5 10% energy transmittance; O.D. 2 5 1%; O.D. 3 = 0.1%, etc.) → there is a 10-fold increase in eye protection for each additional O.D. unit
Additional general lasser points for consideration
There are increased risks of dyspigmentation with some
energy-based devices in darker skin types
Strong sun protective counseling is key; avoid treating
tanned skin
Decrease laser settings to avoid complications (consider
fewer passes, lower joules, decreased surface area treated, and nonablative procedures)
Isotretinoin and dermatologic procedures:
■
New data suggests insufcient evidence to delay treatment with hair removal lasers, vascular lasers, and
5000
484